London · Delayed Price · Currency is GBP · Price in SEK Active Biotech AB Statistics
Total Valuation
LON:0GQU has a market cap or net worth of GBP 8.36 million. The enterprise value is 7.65 million.
| Market Cap | 8.36M |
| Enterprise Value | 7.65M |
Important Dates
The last earnings date was Thursday, February 12, 2026.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 2.64B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +211.51% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.39% |
| Owned by Institutions (%) | 7.51% |
| Float | 2.05B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 23.53 |
| P/TBV Ratio | 24.63 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.52 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.09.
| Current Ratio | 1.17 |
| Quick Ratio | 1.17 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -219.45 |
Financial Efficiency
Return on equity (ROE) is -1,305.02% and return on invested capital (ROIC) is -592.09%.
| Return on Equity (ROE) | -1,305.02% |
| Return on Assets (ROA) | -152.20% |
| Return on Invested Capital (ROIC) | -592.09% |
| Return on Capital Employed (ROCE) | -792.67% |
| Weighted Average Cost of Capital (WACC) | 11.98% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -607,892 |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.33% in the last 52 weeks. The beta is 1.39, so LON:0GQU's price volatility has been higher than the market average.
| Beta (5Y) | 1.39 |
| 52-Week Price Change | -64.33% |
| 50-Day Moving Average | 0.11 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 23.67 |
| Average Volume (20 Days) | 174,441 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.07M |
| Pretax Income | -3.04M |
| Net Income | -3.04M |
| EBITDA | -2.94M |
| EBIT | -3.07M |
| Earnings Per Share (EPS) | -0.00 |
Balance Sheet
The company has 718,455 in cash and 31,580 in debt, with a net cash position of 686,874.
| Cash & Cash Equivalents | 718,455 |
| Total Debt | 31,580 |
| Net Cash | 686,874 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 355,280 |
| Book Value Per Share | 0.00 |
| Working Capital | 165,797 |
Cash Flow
| Operating Cash Flow | -2.91M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LON:0GQU does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -211.51% |
| Shareholder Yield | -211.51% |
| Earnings Yield | -36.35% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |